Accessibility Menu
 
SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF logo

SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF

(NYSEMKT) XPH

Current Price$57.94
Market CapN/A
Since IPO (2006)+416%
5 Year+24%
1 Year+45%
1 Month+12%

SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF Financials at a Glance

Market Cap

N/A

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.37

Beta (Volatility)

0.00 (Low)

Price

$57.94

Volume

0

Open

$58.88

Previous Close

$57.94

Daily Range

$57.81 - $58.88

52-Week Range

$38.95 - $59.46

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF

Industry

Capital Markets

Headquarters

Boston, MA 2210, US

XPH Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$0.00

Shares Outstanding

6.15M

Volume

0

Avg. Volume

0

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Net Cash

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
XESState Street SPDR S&P Oil & Gas Equipment & Services ETF
$127.93+0.24%
XTLState Street SPDR S&P Telecom ETF
$211.79-1.75%
XTNState Street SPDR S&P Transportation ETF
$104.45-0.25%
DFEWisdomTree Europe SmallCap Dividend Fund
$75.25-0.30%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.46+0.01%
NOKNokia
$10.96+0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$61.01-0.03%
BBBYBeyond, Inc.
$5.47+0.02%

Questions About XPH

What is the current price of SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF?

SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF is trading at $57.94 per share.

What is the 52-week range for SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF?

Over the past 52 weeks, SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF has traded between $38.95 and $59.46.

How much debt does SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF have?

SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF total debt is unavailable.

How much cash does SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF have on hand?

SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF does not have cash on hand data available.

What is SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF’s dividend yield?

SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.